EUVIMEDEUVIMED entdecken
Open Access

Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment

Peihang Jiang iD, Fangyang Huang, Liqiang Chen, Hao Zhou, Yudi Deng iD, Lian Li iD, Mao Chen iD, Yuan Huang iD

Science Advances · 14.02.2025 · 11 (7)

DOI: 10.1126/sciadv.adr4333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.02.2025. Verfasst von Peihang Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Extracellular Traps, Myocardial Ischemia, Neutrophils, Sarcoplasmic Reticulum. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia-reperfusion injury (MIRI) often leads to irreversible myocardium dysfunction, while existing therapies are palliatives that transiently alleviate the disease symptoms. Repairing sarcoplasmic reticulum Ca 2+ -ATPase (SERCA) could reverse MIRI, which, however, requires precise drug delivery to the sarcoplasmic reticulum (SR). To this end, we leverage cell-cell “NETwork” of neutrophils to deliver SERCA activator-loaded SR-localized nanoparticles (L-P-NPs) to the damaged myocardial cells, following a hierarchical targeting process: (i) chemotactic neutrophils deliver L-P-NPs to ischemia-reperfused heart, achieving tissue level targeting; (ii) neutrophils produce neutrophil extracellular traps (NETs) to transport L-P-NPs to injured myocardial cell, achieving cellular level targeting; (iii) L-P-NPs escort therapeutic payloads to the SR, achieving subcellular targeting. We showed that this platform profoundly restored SERCA activity, augmented cardiac function, and ameliorated adverse heart remodeling. Our study provides insight into the direct restoration of SR for the effective treatment of MIRI and other muscle diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsMyocardial IschemiaNeutrophilsSarcoplasmic ReticulumMyocardial Reperfusion InjuryAnimalsHumansMiceCell LineDrug Delivery SystemsHuman Umbilical Vein Endothelial CellsMice, Inbred C57BLMyocytes, CardiacNanoparticlesSarcoplasmic Reticulum Calcium-Transporting ATPases

Substanzen

Sarcoplasmic Reticulum Calcium-Transporting ATPases

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
  • Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases and Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Peihang Jiang, Yudi Deng, Lian Li, Mao Chen, Yuan Huang

Zitieren

APA

Jiang, P., Huang, F., Chen, L., Zhou, H., Deng, Y., Li, L., Chen, M., & Huang, Y. (2025). Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment. Science Advances, 11(7). https://doi.org/10.1126/sciadv.adr4333

Vancouver

Jiang P, Huang F, Chen L, Zhou H, Deng Y, Li L, et al. Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment. Science Advances. 2025;11(7). doi:10.1126/sciadv.adr4333

BibTeX
@article{Jiang2025,
  author = {Jiang, Peihang and Huang, Fangyang and Chen, Liqiang and Zhou, Hao and Deng, Yudi and Li, Lian and Chen, Mao and Huang, Yuan},
  title = {Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {7},
  doi = {10.1126/sciadv.adr4333}
}
Kostenlos starten →